Research
And Grants
To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $22,574,694 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 139 grants at over 100 hospitals in 17 countries.

Children's Cancer Institute - $81,683
$81,683.00
February 2015
Facilitates Chromatin Transcription Complex (FACT): A novel therapeutic target against Diffuse Intrinsic Pontine Glioma.

Cincinnati Children's Hospital Medical Center - $100,000
$100,000.00
February 2015
Epigenetic alterations as therapeutic targets in pediatric brain tumors

Cincinnati Children's Hospital - $176,186
$176,186.00
November 2014
International DIPG Registry

University of California, San Francisco - $100,000
$100,000.00
September 2014
Single-cell profiling and targeting of developmentally regulated signaling programs in DIPG.

VU University Medical Center - $30,529
$30,529.00
September 2014
European DIPG Registry

Institute of Cancer Research - $95,325
$95,325.00
September 2014
The evolutionary dynamics of DIPG

The Hospital of Sick Children - $99,400
$99,400.00
September 2014
Development of subgroup-specific models of paediatric DIPG

Duke University Medical Center - $85,394
$85,394.00
November 2013
Development of peptide vaccine for diffuse intrinsic pontine glioma

Yale University - $100,000
$100,000.00
November 2013
Pre-Clinical Development of Novel DIPG Radiosensitizers

Monash Institute of Medical Research - $99,620
$99,620.00
November 2013
Targeted Therapy and Stem Cell Therapy for DIPG

Cincinnati Children's Hospital - $205,000
$205,000.00
November 2013
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry

Ann and Robert H. Lurie Children's Hospital of Chicago - $100,000
$100,000.00
November 2013
Ex-vivo expanded natural killer (NK) cells to target DIPG tumor cells in pre-clinical studies

The Hospital of Sick Children - $100,000
$100,000.00
November 2013
Investigating Mechanisms of Therapeutic Resistance in DIPG.

Dana-Farber Cancer Institute - $50,000
$50,000.00
November 2013
Phase II Trial of Molecularly Determined Treatment of Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas.

Texas Children's Cancer Center - $100,000
$100,000.00
November 2013
Targeting DIPGs in vivo in Intra-brain Stem Xenograft Mouse Models through Combined Radiation and Oncolytic Viral Therapy.